Table 2 Data completion for research outcomes
| Â | Control | MBCT | Total | Missing/Invalid |
|---|---|---|---|---|
Total consented and randomised | 22 | 22 | 44 | n/a |
Dropped out | Â | Â | Â | Â |
Prior start of MBCT | 0 | 1 | 1 | n/a |
Prior to MBCT completion | 10 | 9 | 19 | n/a |
Prior to 6 month follow up | 0 | 0 | 0 | n/a |
Baseline BDI-II | 22 | 21 | 43 | 1 |
Post-MBCT completion BDI-II | 12 | 12 | 24 | 20 |
6-month follow-up BDI-II | 12 | 12 | 24 | 20 |
Baseline STAI-Y1 | 21 | 20 | 41 | 3 |
Post-MBCT completion STAI-Y1 | 12 | 12 | 24 | 20 |
6-month follow-up STAI-Y1 | 12 | 12 | 24 | 20 |
Baseline STAI-Y2 | 22 | 20 | 42 | 2 |
Post-MBCT completion STAI-Y2 | 12 | 12 | 24 | 20 |
6 month follow up STAI-Y2 | 12 | 12 | 24 | 20 |
Baseline MAAS | 22 | 22 | 44 | 0 |
Post MBCT completion MAAS | 12 | 12 | 24 | 20 |
6-month follow-up MAAS | 12 | 12 | 24 | 20 |
Baseline IBDQ | 21 | 21 | 42 | 2 |
Post-MBCT completion IBDQ | 12 | 12 | 24 | 20 |
6-month follow-up IBDQ | 12 | 12 | 24 | 20 |
Baseline DA | 21 | 22 | 23 | 1 |
Post-MBCT completion DA | 12 | 12 | 24 | 20 |
6-month follow-up DA | 12 | 12 | 24 | 20 |